Stay updated on Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added. The previous revision label v3.5.3 has been replaced in the page's history.
    Difference
    0.1%
    Check dated 2026-05-17T10:29:06.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page footer revision number was incremented from v3.5.2 to v3.5.3, reflecting an update to the site’s release/version rather than study details or terms.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:34.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:36:47.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added to the page, and Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-20T19:51:45.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The interface now shows Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:06:55.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    The page now shows revision v3.4.2, replacing v3.4.1. This is a maintenance update and does not alter the study details, eligibility, or results.
    Difference
    0.1%
    Check dated 2026-02-13T01:42:30.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.